ANDA 210252, held by Bionpharma. Fingolimod Hydrochloride.
As of Nov 16, 2026, ANDA 210252 (Fingolimod Hydrochloride), held by Bionpharma, was first approved by FDA on May 24, 2023, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 24, 2023 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fingolimod HydrochlorideEQ 0.5MG BASE · capsule;oral | Fingolimod Hydrochloride | Rx |
| Apr 15, 2024 | Supplement 1Labeling · Standard review | Approved | None posted |
| May 24, 2023 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters